Cancer clinical trial results kept hidden from public

• A combination of industry secrecy, lack of money and shortage of time is keeping the results of many clinical cancer trials locked away and depriving doctors of crucial information, campaigners said on Monday.
• Officials from Cancer Research UK said that while strongly positive and strongly negative trial results did see the light of day very quickly, they were the minority and that middle of the road results often remained a secret.
• Special Partner Promotion Transform your dwelling into a dream home with Intel's Digital Home Planner.
• "One quarter of large scale clinical trials are never published," Richard Sullivan, head of clinical programs at the cancer pressure group, told the annual meeting of the British Association for the Advancement of Science.
• "It is disturbing to think that important information on these trials is being left to gather dust," he added.
• Professor Fran Balkwill, also from Cancer research UK, said one of the reasons was industry secrecy but another was that people were also reluctant to use time or space to publish marginal or negative data.
• Sullivan said that because of the lack of regulation in the industry, one-third of clinical trials were never even registered let alone published.
• He called for all clinical trials to be registered centrally and for all results to have been published within five years of completion.
• Not only would this ensure that knowledge was available to all, it would also save time and large amounts of money by avoiding unnecessary duplication, which in Britain alone amounted to hundreds of thousands of pounds.
• He said companies had a responsibility to society to issue their trial results to avoid waste and ensure that standard practice was not unduly influenced by outcomes that favored only the positive.
• Cancer Stem Cells Hint at Cure Aug. 11, 2004